bioRxivCancer BiologyPreprint
KSHV upregulates the long non-coding RNA PURPL via p73 to suppress p53
Samia Showgan, Diana Meary, Guy Journo, Vyacheslav Gurevich, Meir ShamayiD
Abstract
Long non-coding RNAs (lncRNAs) are a class of regulatory RNAs with lengths exceeding 200 nucleotides. The lncRNA PURPL (p53 upregulated regulator of p53 levels) is a p53-regulated gene. PURPL is an oncogenic lncRNA that represses p53 function; it is upregulated in many tumors and promotes cancer cell proliferation. Kaposi sarcoma-associated herpesvirus (KSHV) is the causative agent of all forms of Kaposi sarcoma (KS) and is tightly associated with primary effusion lymphoma (PEL). We found upregulation of PURPL in both de novo and chronically KSHV-infected cells. We found that p73 (a p53 homolog) associates with the PURPL promoter and upregulates PURPL expression. Previously, it has been shown that KSHV-encoded latency-associated nuclear antigen (LANA) stabilizes p73. We found that ectopic expression of LANA increased both p73 protein levels and PURPL expression. p73 knockdown abrogates PURPL upregulation following KSHV infection. Antisense oligonucleotides (ASO) targeting PURPL reduced PEL cell proliferation and increased acetylated p53 levels. In contrast to p53, p73 is not repressed by PURPL RNA. In summary, our study reveals how an oncogenic virus can utilize p73 to upregulate the oncogenic lncRNA PURPL as an additional way to repress p53. Moreover, we propose another mechanism by which p73 may promote tumor growth.
- organism: human
- assay: long-read sequencing
- research focus: differential expression
- research focus: gene regulatory network inference
- research focus: drug response / drug discovery
- approach: statistical model
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A virus-induced circular RNA maintains latent infection of Kaposi sarcoma herpesvirus
T. Tagawa, D. Oh, … J. M. Ziegelbauer·bioRxiv·Jul 18, 2022
- A non-coding RNA network involved in KSHV tumorigenesis
J. Naipauer, M. E. Garcia Sola, … E. Lacunza·bioRxiv·Mar 5, 2021
- Host microRNA-31-5p represses oncogenic herpesvirus lytic reactivation by restricting the RNA-binding protein KHDRBS3-mediated viral gene expression
Soo Mi Lee, Christopher L. Avalos, … Frank John Slack·bioRxiv·Jan 22, 2025
- Nuclear body assembly by a viral repeat RNA promotes Kaposi's sarcoma-associated herpesvirus gene expression
Mariel Kleer, Rory P. Mulloy, … Jennifer A. Corcoran·Molecular CellPeer-reviewed·Sep 16, 2026
- Inhibition of polo-like kinase 1 (PLK1) facilitates reactivation of gamma-herpesviruses in B-cell lymphomas and their elimination
A. Biswas, G. N. Fiches, … N. G. Santoso·bioRxiv·Oct 8, 2020
- Polycomb group proteins protect latent Kaposi sarcoma-associated herpesvirus from episome clearance and HUSH-dependent chromatin silencing
Simon Weissmann, Alexis Robitaille, … Adam T. Grundhoff·bioRxiv·Feb 10, 2025